BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (NOVEMBER DECEMBER 2012)

Recent Developments in Clinical Research (India)

S K Gupta, Binit Kumar

Introduction:
 
The number of clinical trials conducted in India is still increasing. According to a report created by the Federation of Indian Chambers of Commerce and Industry in co-operation with the consulting firm Ernst & Young, as many as 7% of all clinical phase III studies performed worldwide are already carried out in India. For phase II studies, the percentage is 3.2. In the 15 months preceding the report creation alone, the number of industry-sponsored phase II and phase III test facility increased by 116% (reaching 2.299). This makes India the 12th most active country in this field worldwide (within Asia, it ranks second after Japan). The number of clinical investigators has also gone up by 54% since 2002.

 

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright KONGPOSH PUBLICATIONS Pvt. Ltd.